These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 17702962)
1. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Iwai M; Cao G; Yin W; Stetler RA; Liu J; Chen J Stroke; 2007 Oct; 38(10):2795-803. PubMed ID: 17702962 [TBL] [Abstract][Full Text] [Related]
2. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Iwai M; Stetler RA; Xing J; Hu X; Gao Y; Zhang W; Chen J; Cao G Stroke; 2010 May; 41(5):1032-7. PubMed ID: 20360553 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia. Zhu L; Bai X; Wang S; Hu Y; Wang T; Qian L; Jiang L Neonatology; 2014; 106(2):143-8. PubMed ID: 24969821 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Demers EJ; McPherson RJ; Juul SE Pediatr Res; 2005 Aug; 58(2):297-301. PubMed ID: 16055937 [TBL] [Abstract][Full Text] [Related]
7. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Spandou E; Papadopoulou Z; Soubasi V; Karkavelas G; Simeonidou C; Pazaiti A; Guiba-Tziampiri O Brain Res; 2005 May; 1045(1-2):22-30. PubMed ID: 15910759 [TBL] [Abstract][Full Text] [Related]
8. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Sun Y; Calvert JW; Zhang JH Stroke; 2005 Aug; 36(8):1672-8. PubMed ID: 16040592 [TBL] [Abstract][Full Text] [Related]
9. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Wang L; Zhang Z; Wang Y; Zhang R; Chopp M Stroke; 2004 Jul; 35(7):1732-7. PubMed ID: 15178821 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin Ameliorates Neonatal Hypoxia-Ischemia-Induced Neurobehavioral Deficits, Neuroinflammation, and Hippocampal Injury in the Juvenile Rat. Lan KM; Tien LT; Cai Z; Lin S; Pang Y; Tanaka S; Rhodes PG; Bhatt AJ; Savich RD; Fan LW Int J Mol Sci; 2016 Feb; 17(3):289. PubMed ID: 26927081 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats. Pellegrini L; Bennis Y; Guillet B; Velly L; Garrigue P; Sabatier F; Dignat-George F; Bruder N; Pisano P Neurol Res; 2013 Nov; 35(9):937-47. PubMed ID: 23816235 [TBL] [Abstract][Full Text] [Related]
12. Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway. Yu DF; Zhu LH; Jiang L Chin Med J (Engl); 2017 Apr; 130(7):854-858. PubMed ID: 28345550 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. Kim SS; Lee KH; Sung DK; Shim JW; Kim MJ; Jeon GW; Chang YS; Park WS J Korean Med Sci; 2008 Jun; 23(3):484-91. PubMed ID: 18583887 [TBL] [Abstract][Full Text] [Related]
14. Multi-modal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. van de Looij Y; Chatagner A; Quairiaux C; Gruetter R; Hüppi PS; Sizonenko SV PLoS One; 2014; 9(4):e95643. PubMed ID: 24755676 [TBL] [Abstract][Full Text] [Related]
15. Combination of deferoxamine and erythropoietin: therapy for hypoxia-ischemia-induced brain injury in the neonatal rat? van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F Neurosci Lett; 2009 Feb; 451(2):109-13. PubMed ID: 19103262 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Fan X; Heijnen CJ; van der KOOIJ MA; Groenendaal F; van Bel F Pediatr Res; 2011 Jan; 69(1):56-61. PubMed ID: 20856165 [TBL] [Abstract][Full Text] [Related]
17. Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury. Mazur M; Miller RH; Robinson S J Neurosurg Pediatr; 2010 Sep; 6(3):206-21. PubMed ID: 20809703 [TBL] [Abstract][Full Text] [Related]
18. The Akt/mTOR/p70S6K Pathway Is Involved in the Neuroprotective Effect of Erythropoietin on Hypoxic/Ischemic Brain Injury in a Neonatal Rat Model. Lee HJ; Koh SH; Song KM; Seol IJ; Park HK Neonatology; 2016; 110(2):93-100. PubMed ID: 27070481 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin reduces hippocampus injury in neonatal rats with hypoxic ischemic brain damage via targeting matrix metalloprotein-2. Zhang L; Wang L; Ning FB; Wang T; Liang YC; Liu YL Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4327-4333. PubMed ID: 29077163 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia. Spandou E; Soubasi V; Papoutsopoulou S; Karkavelas G; Simeonidou C; Kaiki-Astara A; Guiba-Tziampiri O Neurosci Lett; 2004 Aug; 366(1):24-8. PubMed ID: 15265583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]